Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (441-450 of 692) with videos related to

Pageof 70
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 12, 2010
Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimensRemco M van den Berg, Peter J F Snijders, Katrien Grünberg, et al.
The European Respiratory Journal|March 14, 2009
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathyM J Overbeek, M C Vonk, A Boonstra, et al.
The Journal of Molecular Diagnostics : JMD|January 29, 2025
Analytical and Clinical Validation of the Plasma-Based Guardant360 CDx Test for Assessing HER2 (ERBB2) Mutation Status in Patients with Non-Small-Cell Lung Cancer for Treatment with Trastuzumab Deruxtecan in DESTINY-Lung01/02Zhenhao Qi, Shinya Tokuhiro, Justin I Odegaard, et al.
Oral Oncology|August 5, 2021
Management and outcome of middle ear adenomatous neuroendocrine tumours: A systematic reviewM S D Engel, R J L van der Lans, J C Jansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975F Efficace, A Bottomley, E F Smit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative GroupP E Postmus, H Haaxma-Reiche, E F Smit, et al.
Oncoimmunology|July 4, 2015
Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancerPauline L de Goeje, Koen Bezemer, Marlies E Heuvers, et al.
Nuclear Medicine and Biology|July 29, 2014
Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumorsPaul Slobbe, Albert D Windhorst, Marijke Stigter-van Walsum, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2007
CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasoneRemco M van den Berg, H Jelle Teertstra, Nico van Zandwijk, et al.
International Journal of Cancer|August 2, 2014
Sorafenib synergizes with metformin in NSCLC through AMPK pathway activationFloris H Groenendijk, Wouter W Mellema, Eline van der Burg, et al.
Pageof 70

Showing results (441-450 of 692) with videos related to

Sort By:
Pageof 70
Lung Cancer (Amsterdam, Netherlands)|November 12, 2010
Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimensRemco M van den Berg, Peter J F Snijders, Katrien Grünberg, et al.
The European Respiratory Journal|March 14, 2009
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathyM J Overbeek, M C Vonk, A Boonstra, et al.
The Journal of Molecular Diagnostics : JMD|January 29, 2025
Analytical and Clinical Validation of the Plasma-Based Guardant360 CDx Test for Assessing HER2 (ERBB2) Mutation Status in Patients with Non-Small-Cell Lung Cancer for Treatment with Trastuzumab Deruxtecan in DESTINY-Lung01/02Zhenhao Qi, Shinya Tokuhiro, Justin I Odegaard, et al.
Oral Oncology|August 5, 2021
Management and outcome of middle ear adenomatous neuroendocrine tumours: A systematic reviewM S D Engel, R J L van der Lans, J C Jansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975F Efficace, A Bottomley, E F Smit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative GroupP E Postmus, H Haaxma-Reiche, E F Smit, et al.
Oncoimmunology|July 4, 2015
Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancerPauline L de Goeje, Koen Bezemer, Marlies E Heuvers, et al.
Nuclear Medicine and Biology|July 29, 2014
Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumorsPaul Slobbe, Albert D Windhorst, Marijke Stigter-van Walsum, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2007
CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasoneRemco M van den Berg, H Jelle Teertstra, Nico van Zandwijk, et al.
International Journal of Cancer|August 2, 2014
Sorafenib synergizes with metformin in NSCLC through AMPK pathway activationFloris H Groenendijk, Wouter W Mellema, Eline van der Burg, et al.
Pageof 70